Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Factory Orders Edge Higher; G7 to Release Diesel, Crude
Business & Finance

Factory Orders Edge Higher; G7 to Release Diesel, Crude

Bloomberg Markets Friday 02 October 2026, 14:36 UTC 1 min read
Key Points

US factory orders rose by 0.1% month-over-month in August. Michael McKee breaks down the numbers and also discusses the G7's plans to release as much as 100 million barrels of emergency oil and diesel stocks on "Bloomberg Open Interest."

US factory orders rose by 0.1% month-over-month in August. Michael McKee breaks down the numbers and also discusses the G7's plans to release as much as 100 million barrels of emergency oil and diesel stocks on "Bloomberg Open Interest." (Source: Bloomberg)
G7 (ORG) Release Diesel (ORG) US (LOCATION) Michael McKee (PERSON)
Originally published by Bloomberg Markets Read original →

Related Stories

AT&T, T-Mobile and Verizon have officially teamed up to end coverage gaps

AT&T, T-Mobile and Verizon have officially teamed up to end coverage gaps This is likely an attempt to get ahead of potential rivals like Starlink and Leo. AT&T, T-Mobile and Verizon have teamed up to try to eliminate mobile coverage dead zones. The three companies have entered into an unnamed joint venture that will use satellites to help close coverage gaps in areas where traditional service is limited.

Engadget 5m ago

Why U.S. Diesel Is So Important to Major Trading Partners

Adjusting the price of gasoline in Porto Alegre, Brazil, this year.

NYT World 17m ago

Why does Anthropic’s IPO feel so weird?

Compared to other blockbuster share sales, the build-up to the AI company’s stock market debut has felt discordant, even creepy

Financial Times 22m ago

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines. Instead, drugmakers are developing treatments that can complement existing drugs and push weight loss further, or offer new options for potentially millions of people who may not get enough benefit from GLP-1s. That's the early potential of a new slate of injections, pills, and combination regimens targeting the amylin pathway, which involves a hormone released in the pancreas alongside insulin that...

CNBC 22m ago